These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17409457)

  • 1. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
    Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
    Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
    Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
    EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
    Kalniņa Z; Siliņa K; Meistere I; Zayakin P; Rivosh A; Abols A; Leja M; Minenkova O; Schadendorf D; Linē A
    J Immunol Methods; 2008 May; 334(1-2):37-50. PubMed ID: 18314130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
    Albertus DL; Seder CW; Chen G; Wang X; Hartojo W; Lin L; Silvers A; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Bigbee WL; Chinnaiyan AM; Beer DG
    J Thorac Oncol; 2008 Nov; 3(11):1236-44. PubMed ID: 18978557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
    Madoz-Gúrpide J; Kuick R; Wang H; Misek DE; Hanash SM
    Mol Cell Proteomics; 2008 Feb; 7(2):268-81. PubMed ID: 17916591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
    Zhong L; Coe SP; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
    J Thorac Oncol; 2006 Jul; 1(6):513-9. PubMed ID: 17409910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
    Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
    Pereira-Faca SR; Kuick R; Puravs E; Zhang Q; Krasnoselsky AL; Phanstiel D; Qiu J; Misek DE; Hinderer R; Tammemagi M; Landi MT; Caporaso N; Pfeiffer R; Edelstein C; Goodman G; Barnett M; Thornquist M; Brenner D; Hanash SM
    Cancer Res; 2007 Dec; 67(24):12000-6. PubMed ID: 18089831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated autoantibody signature for the early detection of gastric cancer.
    Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
    Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of NSCLC with scFv selected against IgM autoantibody.
    Pedchenko T; Mernaugh R; Parekh D; Li M; Massion PP
    PLoS One; 2013; 8(4):e60934. PubMed ID: 23585862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
    Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
    Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteome analysis of autoantibodies in sera of patients with cancer].
    Ueda K
    Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.
    Schmitt J; Heisel S; Keller A; Leidinger P; Ludwig N; Habel N; Furtwängler R; Nourkami-Tutdibi N; Wegert J; Grundy P; Gessler M; Graf N; Lenhof HP; Meese E
    Int J Cancer; 2012 Aug; 131(3):673-82. PubMed ID: 21913182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.
    Brichory F; Beer D; Le Naour F; Giordano T; Hanash S
    Cancer Res; 2001 Nov; 61(21):7908-12. PubMed ID: 11691811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-1 autoantibody as a new potential biomarker for cervical carcinoma.
    Tong YQ; Liu B; Zheng HY; He YJ; Gu J; Li F; Li Y
    PLoS One; 2011; 6(11):e27804. PubMed ID: 22132147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
    Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
    Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody signatures in prostate cancer.
    Wang X; Yu J; Sreekumar A; Varambally S; Shen R; Giacherio D; Mehra R; Montie JE; Pienta KJ; Sanda MG; Kantoff PW; Rubin MA; Wei JT; Ghosh D; Chinnaiyan AM
    N Engl J Med; 2005 Sep; 353(12):1224-35. PubMed ID: 16177248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel autoantibodies for detection of malignant mesothelioma.
    Zhang X; Shen W; Dong X; Fan J; Liu L; Gao X; Kernstine KH; Zhong L
    PLoS One; 2013; 8(8):e72458. PubMed ID: 23977302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.